Skip to main content

Table 1 Patients’ characteristics

From: Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters

Patients, n

16

Patients with unilateral lesions, n

14

Patients with bilateral lesions, n

2

Number of PCa lesions analyzed, n

18

Median age in years (range)

70.5 (61–79)

Median PSA before imaging in ng/ml (range)

6.42 (2.1–27.9)

Patients with PSMA PET/CT, n

16

  18F PSMA PET

14

  68 Ga PSMA PET

2

Patients with mpMRI, n

16

  1.5 T

2

  3 T

14

Gleason score in biopsy cores, n

 

  6

2

  7a

7

  7b

3

  8

4

  9

0

  10

0

Patients with previous ADT, n

8

  1. ADT, androgen deprivation therapy; mpMRI, multiparametric magnetic resonance imaging; PCa, prostate cancer; PSA, prostateserum antigen; PSMA PET, prostate-specific membrane antigen positron emission tomography; T, Tesla